Aisling Capital Management as of June 30, 2025
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 13 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 72.9 | $262M | 6.1M | 43.18 | |
| Verona Pharma Sponsored Ads (VRNA) | 16.2 | $58M | 615k | 94.58 | |
| Syndax Pharmaceuticals (SNDX) | 3.4 | $12M | 1.3M | 9.36 | |
| Monte Rosa Therapeutics (GLUE) | 1.8 | $6.6M | 1.5M | 4.51 | |
| Bicara Therapeutics (BCAX) | 1.5 | $5.3M | 569k | 9.29 | |
| Nuvation Bio Com Cl A (NUVB) | 1.4 | $5.0M | 2.5M | 1.95 | |
| Biomea Fusion (BMEA) | 1.0 | $3.7M | 2.0M | 1.80 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.9 | $3.4M | 1.2M | 2.80 | |
| Elevation Oncology (ELEV) | 0.3 | $1.0M | 2.8M | 0.37 | |
| CalciMedica Com New (CALC) | 0.2 | $834k | 521k | 1.60 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $617k | 435k | 1.42 | |
| Marker Therapeutics Com New (MRKR) | 0.1 | $498k | 325k | 1.53 | |
| OnKure Therapeutics Com Cl A (OKUR) | 0.1 | $212k | 89k | 2.39 |
